Rkl Wealth Management LLC Annovis Bio, Inc. Transaction History

Rkl Wealth Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$30.95 - $120.97 $154,750 - $604,850	-5,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$21.55 - $96.1 $107,750 - $480,500	-5,000 Reduced 50.0%	5,000 $428,000
Q1 2021 May 10, 2021	BUY	$8.15 - $38.44 $81,500 - $384,400	10,000 New	10,000 $279,000

1.17M

229K

934K

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $41.7M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

Get notified when there are updates to the investment portfolio of Rkl Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Rkl Wealth Management LLC with notifications on news.